Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

eFFECTOR Therapeutics Inc (NASDAQ: EFTRW)

 
EFTRW Technical Analysis
5
As on 9th Jun 2023 EFTRW SHARE Price closed @ 0.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.71 & Strong Sell for SHORT-TERM with Stoploss of 1.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EFTRWSHARE Price

Open 0.20 Change Price %
High 0.20 1 Day -0.01 -5.26
Low 0.18 1 Week 0.01 5.88
Close 0.18 1 Month 0.06 50.00
Volume 11727 1 Year -1.00 -84.75
52 Week High 2.25 | 52 Week Low 0.05
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
EFTRW
Daily Charts		 EFTRW
Intraday Charts		 Whats New @
Bazaartrend		 EFTRW
Free Analysis
 
EFTRW Important Levels Intraday
RESISTANCE0.22
RESISTANCE0.21
RESISTANCE0.20
RESISTANCE0.19
SUPPORT0.17
SUPPORT0.16
SUPPORT0.15
SUPPORT0.14
 
EFTRW Forecast April 2024
Share
4th UP Forecast2.01
3rd UP Forecast1.42
2nd UP Forecast1.06
1st UP Forecast0.7
1st DOWN Forecast-0.34
2nd DOWN Forecast-0.7
3rd DOWN Forecast-1.06
4th DOWN Forecast-1.65
 
EFTRW Weekly Forecast
4th UP Forecast3.05
3rd UP Forecast2.13
2nd UP Forecast1.56
1st UP Forecast0.99
1st DOWN Forecast-0.63
2nd DOWN Forecast-1.20
3rd DOWN Forecast-1.77
4th DOWN Forecast-2.69
 
EFTRW Forecast2024
4th UP Forecast4.9
3rd UP Forecast3.39
2nd UP Forecast2.45
1st UP Forecast1.52
1st DOWN Forecast-1.16
2nd DOWN Forecast-2.09
3rd DOWN Forecast-3.03
4th DOWN Forecast-4.54
 
 
EFTRW Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EFTRW Address
EFTRW
 
EFTRW Latest News
 
Your Comments and Response on eFFECTOR Therapeutics Inc
 
EFTRW Business Profile
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service